دورية أكاديمية
Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
العنوان: | Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure |
---|---|
المؤلفون: | E. V. Kovalenko, M. V. Lozhkina, G. G. Arabidze, V. G. Kryakushkin |
المصدر: | Российский кардиологический журнал, Vol 26, Iss 1 (2021) |
بيانات النشر: | «FIRMA «SILICEA» LLC, 2021. |
سنة النشر: | 2021 |
المجموعة: | LCC:Diseases of the circulatory (Cardiovascular) system |
مصطلحات موضوعية: | heart failure, type 2 diabetes, sodium-glucose co-transporter-2 inhibitor, empagliflozin, dapagliflozin, canagliflozin, ertugliflozin, sotagliflozin, Diseases of the circulatory (Cardiovascular) system, RC666-701 |
الوصف: | The article analyzes the new results of randomized clinical trials on the use of sodium-glucose co-transporter-2 inhibitors in patients with cardiovascular diseases, heart failure with and without type 2 diabetes. The data of the latest studies (EMPEROR reduced, VERTIS CV, SOLOIST-WHF, SCORED) are presented in more detail. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | Russian |
تدمد: | 1560-4071 2618-7620 |
Relation: | https://russjcardiol.elpub.ru/jour/article/view/4235; https://doaj.org/toc/1560-4071; https://doaj.org/toc/2618-7620 |
DOI: | 10.15829/1560-4071-2021-4235 |
URL الوصول: | https://doaj.org/article/5390d165b7604afb80f353006d00b7ba |
رقم الأكسشن: | edsdoj.5390d165b7604afb80f353006d00b7ba |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 15604071 26187620 |
---|---|
DOI: | 10.15829/1560-4071-2021-4235 |